Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | ||||||
{[ item.p_purity ]} | {[ item.pr_size ]} | Inquiry |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price) ]} |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price) ]} | {[ item.pr_usastock ]} | in stock Inquiry - | {[ item.pr_chinastock ]} | {[ item.pr_remark ]} in stock Inquiry - | Login | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
N-Arylpyrazole NOD2 Agonists Promote Immune Checkpoint Inhibitor Therapy
Griffin, Matthew E. ; Tsukidate, Taku ; Hang, Howard C. ACS Chem. Biol.,2023,18(6):1368-1377. DOI: 10.1021/acschembio.3c00085 PubMed ID: 37172210
More
Abstract: The characterization of microbiota mechanisms in health and disease has reinvigorated pattern recognition receptors as prominent targets for immunotherapy. Notably, our recent studies on Enterococcus species revealed peptidoglycan remodeling and activation of NOD2 as key mechanisms for microbiota enhancement of immune checkpoint inhibitor therapy. Inspired by this work and other studies of NOD2 activation, we performed in silico ligand screening and developed N-arylpyrazole dipeptides as novel NOD2 agonists. Importantly, our N-arylpyrazole NOD2 agonist is enantiomer-specific and effective at promoting immune checkpoint inhibitor therapy and requires NOD2 for activity in vivo. Given the significant functions of NOD2 in innate and adaptive immunity, these next-generation agonists afford new therapeutic leads and adjuvants for a variety of NOD2-responsive diseases.
Purchased from AmBeed: 1821-12-1 ; 14290-86-9 ; 220353-04-8 ; 241798-62-9 ; 288251-63-8 ; 241798-56-1
CAS No. : | 1821-12-1 | MDL No. : | MFCD00004403 |
Formula : | C10H12O2 | Boiling Point : | - |
Linear Structure Formula : | HOOCCH2CH2CH2C6H5 | InChI Key : | OBKXEAXTFZPCHS-UHFFFAOYSA-N |
M.W : | 164.20 | Pubchem ID : | 4775 |
Synonyms : |
4-PBA;Benzenebutyric acid
|
Chemical Name : | 4-Phenylbutanoic acid |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
42% | With sulfuric acid; iodine; acetic acid; periodic acid In water at 70℃; for 19 h; | A mixture of 4-phenylbutanoic acid (20.0 g, 121.8 mmol), H5IO6 (5.56 g, 24.4 mmol), iodine (13.30 g, 52.4 mmol), 10 M H2SO4 (5.0 mL), water (36 mL) and acetic acid (166 mL) was heated at 70° C. for 19 h. The reaction mixture was cooled and evaporated to dryness. The residue was dissolved in EtOAc (300 mL) and washed with aqueous Na2S2O3 (2*200 mL), brine (2*200 mL), dried over Na2SO4, filtered, and evaporated to leave a yellow solid. The crude product was precipitated from EtOAc/hexane at 0° C. to afford product as light yellow solid (15.0 g, 42percent). 1H NMR (400 MHz, CDCl3) δ 11.0 (brs, 1H), 7.61 (d, J=8.4 Hz, 2H), 6.95 (d, J=8.0 Hz, 2H), 2.63 (t, J=7.6 Hz, 2H), 2.38 (t, J=7.6 Hz, 2H). |
[ 22084-89-5 ]
3-(2-Methylphenyl)propionic acid
Similarity: 1.00
[ 5467-53-8 ]
4-(4-Ethylphenyl)butanoic acid
Similarity: 1.00
[ 3751-48-2 ]
3-(3-Methylphenyl)propionic acid
Similarity: 1.00
[ 42287-87-6 ]
3-(3,5-Dimethylphenyl)propanoic acid
Similarity: 1.00
[ 22084-89-5 ]
3-(2-Methylphenyl)propionic acid
Similarity: 1.00
[ 5467-53-8 ]
4-(4-Ethylphenyl)butanoic acid
Similarity: 1.00
[ 3751-48-2 ]
3-(3-Methylphenyl)propionic acid
Similarity: 1.00
[ 42287-87-6 ]
3-(3,5-Dimethylphenyl)propanoic acid
Similarity: 1.00